PATENT CLAIM ANALYSIS

Application Number: 16039301
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "255050"]

Abstract:
1,8-naphthyridinone compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.

Claim (Index 31):
The compound of  claim 1 , or a tautomer or isomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein B is phenyl, optionally further substituted with R 7 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13052544', '14383432', '15875106', '15151259', '14137438']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.78715731188393
- 35 USC 102 Novelty (BERT): 0.5124964770747369
- Combined Prediction Score: 0.7596912284030106
- Mean Citation Score: 284.784172
- Max Citation Score: 292.0291
- Similarity Product: 216.6188343403876

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test